fxs_header_sponsor_anchor

News

BioNTech CEO: New variant might be able to infect vaccinated people

While speaking at an event organized by Reuters on Friday, BioNTech CEO Ugur Sahin said the new variant might be able to infect vaccinated people and people with high exposure to COVID-19.

Additional takeaways

"It's not clear if vaccinated people have sufficient protection to avoid severe disease from new variant, we anticipate vaccinated people will be protected from severe disease."

"This new variant came earlier than I expected, I expected it sometime next year."

"We have the ability to adapt COVID-19 vaccine relatively quickly."

"We are confident that vaccinated people and those with booster shots will have sufficient protection against severe disease and may be any type of disease; we will know in a few weeks."

"The higher rate of immune people, the better we are protected against COVID-19 having the ability to mutate."

"I think we will need a new vaccine against COVID-19, it's a question of when we will need it."

Market reaction

These comments seem to be weighing on market sentiment. As of writing, US stock index futures were down between 0.3% and 0.4%.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2025 FOREXSTREET S.L., All rights reserved.